CDT Equity, Inc. (CDT)
0.91
-0.08
(-8.08%)
USD |
NASDAQ |
Oct 05, 16:00
0.99
+0.08
(+8.79%)
After-Hours: 20:00
CDT Equity Net Income (Quarterly) : -4.641M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.641M |
| March 31, 2026 | -4.063M |
| December 31, 2025 | -21.32M |
| September 30, 2025 | -7.118M |
| June 30, 2025 | -6.028M |
| March 31, 2025 | -4.753M |
| December 31, 2024 | -2.406M |
| September 30, 2024 | -6.461M |
| June 30, 2024 | -5.383M |
| March 31, 2024 | -3.571M |
| Date | Value |
|---|---|
| December 31, 2023 | 1.779M |
| September 30, 2023 | 2.625M |
| June 30, 2023 | -1.733M |
| March 31, 2023 | -1.672M |
| December 31, 2022 | -3.071M |
| September 30, 2022 | -0.956M |
| June 30, 2022 | -0.1175M |
| March 31, 2022 | -0.2535M |
| December 31, 2021 | -0.0044M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Windtree Therapeutics, Inc. | -28.08M |
| Lifecore Biomedical, Inc. | -6.156M |
| Codexis, Inc. | -12.00M |
| Navidea Biopharmaceuticals, Inc. | -- |
| Biostax Corp. | -- |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.641M |
| EPS Diluted (Quarterly) | -217.68 |
| Enterprise Value | 0.4599M |
| Earnings Yield | -15.57M% |
| Normalized Earnings Yield | -15.50M |